Showing results (911-920 of 960) with videos related to
Sort By:
Pageof 96
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.Circulation Research|December 14, 2023
The Role of <i>MAPRE2</i> and Microtubules in Maintaining Normal Ventricular ConductionDavid Y Chiang, Arie O Verkerk, Rachelle Victorio, et al.Journal of Hepatology|August 12, 2009
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell, Sara Toffanin, Augusto Villanueva, et al.The Journal of Infectious Diseases|April 16, 2023
A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernNicholas P Wayham, Ariel R Niedecken, Jan Fredrik Simons, et al.Frontiers in Pharmacology|June 18, 2024
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapyRajbharan Yadav, Suzanne Schubbert, Patrick G Holder, et al.Circulation|July 21, 2020
Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial FibrillationHannah M Campbell, Ann P Quick, Issam Abu-Taha, et al.Pediatric Transplantation|February 6, 2024
Anti-spike antibody durability after SARS-CoV-2 vaccination in adolescent solid organ transplant recipientsJohn McAteer, Divya D Kalluri, Rivka R Abedon, et al.JACC. Clinical Electrophysiology|November 26, 2022
Atrial Standstill in the Pediatric Population: A Multi-Institution CollaborationTaylor S Howard, David Y Chiang, Scott R Ceresnak, et al.Circulation|June 13, 2019
Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial FibrillationKatherina M Alsina, Mohit Hulsurkar, Sören Brandenburg, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issuesN Aït-Khaled, E Alarcon, K Bissell, et al.Pageof 96